Mirum Pharmaceuticals, Inc. (MIRM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

25.09

-0.82

(-3.17%)

As of 01:17PM EDT. Market open.

Loading interactive chart…

Business Wire
Mirum Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
FOSTER CITY, Calif., May 07, 2024--Mirum Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
Business Wire
Mirum Announces Publication of Phase 3 MARCH Data in The Lancet Demonstrating Benefits of LIVMARLI (maralixibat) in patients with PFIC
FOSTER CITY, Calif., May 07, 2024--Mirum Announces Publication of Phase 3 MARCH Data in The Lancet Demonstrating Benefits of LIVMARLI (maralixibat) in patients with PFIC
Business Wire
Mirum Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
FOSTER CITY, Calif., May 01, 2024--Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report first quarter 2024 financial results on May 8, 2024. Mirum will also host a conference call to discuss the first quarter 2024 financial results and recent corporate progress.